HCL Technologies rises on expanding strategic partnership with Olympus Corporation
HCL Technologies is currently trading at Rs. 1445.75, up by 15.95 points or 1.12% from its previous closing of Rs. 1429.80 on the BSE.
The scrip opened at Rs. 1472.00 and has touched a high and low of Rs. 1472.00 and Rs. 1443.50 respectively. So far 83354 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1696.50 on 23-Feb-2024 and a 52 week low of Rs. 1087.75 on 13-Jul-2023.
Last one week high and low of the scrip stood at Rs. 1472.00 and Rs. 1352.00 respectively. The current market cap of the company is Rs. 394024.17 crore.
The promoters holding in the company stood at 60.81%, while Institutions and Non-Institutions held 34.62% and 4.56% respectively.
HCL Technologies (HCL Tech) has expanded strategic partnership with Olympus Corporation (Olympus), a global MedTech company, to enable advanced and affordable healthcare for patients through cutting-edge engineering technologies.
HCLTech will leverage its global leadership in Engineering and R&D services along with artificial intelligence (AI) based solutions to provide speed and scale to Olympus’ global product development journey. HCLTech will establish a dedicated product innovation center in Hyderabad, India to serve Olympus’ operations across US, Europe, Middle East and Africa. The center is expected to commence operations by July 2024 and boost Olympus’ business expansion plans and drive advancements in medical technology.
HCLTech and Olympus share a decade-long partnership in core Engineering and R&D, spanning product engineering, software engineering, product sustenance, risk and regulatory services. HCLTech serves Olympus from its global delivery centers in India and Vietnam.
HCL Technologies is a leading global IT services company that helps global enterprises reimagines and transforms their businesses through digital technology transformation.